Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Status:
Unknown status
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to explore whether endostar combined with NVB and DDP as treatment
could improve progression-free surial time (PFS) and to evaluate the safety of the
chemotherapy regimens